Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Friborg

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Canadian Family Physician Medecin De Famille Canadien|February 9, 2011
[Not Available]C Beaudry, J Friborg
The American Journal of Physiology|July 1, 1971
Vasodilators, intrarenal blood flow, and natriuresis in the dogS Carrière, J Friborg, J P Guay
L'Union Medicale Du Canada|August 1, 1984
[Evaluation of renal function and preoperative preparation of high-risk patients]R M Girard, J Friborg, R Dandavino
L'Union Medicale Du Canada|June 1, 1981
[Treatment of drug poisoning by tricyclic antidepressant agents: for or against the use of physostigmine]M Dubuc, J Friborg, M Houde, et al.
L'Union Medicale Du Canada|January 1, 1975
[Case of acute intoxication with phencyclidine causing muscle rigidity and acute kidney failure]R Dandavino, J Friborg, C Beaudry, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1972
The effect of furosemide on the intrarenal blood flow distribution in the dogS Carrière, M Desrosiers, J Friborg, et al.
Kidney International|May 1, 1973
[Intrarenal hemodynamic changes during acute isotonic saline loading in the dog (author's transl)]J Friborg, R Mousseau, M G Brunette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2024
Response to the letter by Boon and colleaguesJ Friborg, K Jensen, C Grau, et al.
Toxicology Letters|May 1, 1992
Limited immunotoxic potential of technical formulation of the herbicide atrazine (AAtrex) in miceM Fournier, J Friborg, D Girard, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbonesS Weinheimer, L Discotto, J Friborg, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Canadian Family Physician Medecin De Famille Canadien|February 9, 2011
[Not Available]C Beaudry, J Friborg
The American Journal of Physiology|July 1, 1971
Vasodilators, intrarenal blood flow, and natriuresis in the dogS Carrière, J Friborg, J P Guay
L'Union Medicale Du Canada|August 1, 1984
[Evaluation of renal function and preoperative preparation of high-risk patients]R M Girard, J Friborg, R Dandavino
L'Union Medicale Du Canada|June 1, 1981
[Treatment of drug poisoning by tricyclic antidepressant agents: for or against the use of physostigmine]M Dubuc, J Friborg, M Houde, et al.
L'Union Medicale Du Canada|January 1, 1975
[Case of acute intoxication with phencyclidine causing muscle rigidity and acute kidney failure]R Dandavino, J Friborg, C Beaudry, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1972
The effect of furosemide on the intrarenal blood flow distribution in the dogS Carrière, M Desrosiers, J Friborg, et al.
Kidney International|May 1, 1973
[Intrarenal hemodynamic changes during acute isotonic saline loading in the dog (author's transl)]J Friborg, R Mousseau, M G Brunette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2024
Response to the letter by Boon and colleaguesJ Friborg, K Jensen, C Grau, et al.
Toxicology Letters|May 1, 1992
Limited immunotoxic potential of technical formulation of the herbicide atrazine (AAtrex) in miceM Fournier, J Friborg, D Girard, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbonesS Weinheimer, L Discotto, J Friborg, et al.
Pageof 4